Minimum Net Sales. The Loan Parties shall maintain LTM Net Sales of at least (A) $57,375,000 for the fiscal year ending December 31, 2019 and (B) $76,500,000 for the fiscal year ending December 31, 2020 and each fiscal year ending thereafter.
Appears in 3 contracts
Samples: Convertible Loan Agreement (Melinta Therapeutics, Inc. /New/), Senior Subordinated Convertible Loan Agreement (Melinta Therapeutics, Inc. /New/), Senior Subordinated Convertible Loan Agreement (Melinta Therapeutics, Inc. /New/)
Minimum Net Sales. The Loan Parties shall maintain LTM Net Sales of at least (A) $57,375,000 45,000,000 for the fiscal year ending December 31, 2018, (B) $75,000,000 for the fiscal year ending December 31, 2019 and (BC) $76,500,000 100,000,000 for the fiscal year ending December 31, 2020 and each fiscal year ending thereafter.
Appears in 2 contracts
Samples: Facility Agreement (Melinta Therapeutics, Inc. /New/), Facility Agreement (Melinta Therapeutics, Inc. /New/)
Minimum Net Sales. The Loan Parties shall maintain LTM Net Sales of at least (A) $57,375,000 45,000,000 for the fiscal year ending December 31, 2018, (B) $63,750,000 for the fiscal year ending December 31, 2019 and (BC) $76,500,000 85,000,000 for the fiscal year ending December 31, 2020 and each fiscal year ending thereafter.β
Appears in 1 contract
Samples: Facility Agreement (Melinta Therapeutics, Inc. /New/)
